Solidarity Wealth’s GSK GSK Stock Holding History

Solidarity Wealth’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-5,959	Closed	-$218K	–	87
2023 Q3	$218K	Sell	5,959 -110	-2%	-$3.9K	0.08%	81
2023 Q2	$218K	Sell	6,069 -134	-2%	-$4.81K	0.09%	82
2023 Q1	$223K	Buy	+6,203	New	+$217K	0.1%	88
2022 Q3	$242K	Buy	+7,564	New	+$287K	0.14%	104
2022 Q2	–	Sell	-4,270	Closed	-$245K	–	112
2022 Q1	$245K	Buy	+4,270	New	+$232K	0.14%	105

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Solidarity Wealth's GSK Position: Q4 2023 in Review

Solidarity Wealth sold out of GSK (GSK) in Q4 2023, closing a stake of 5,959 shares — an estimated $218K sold.

Solidarity Wealth first reported a position in GSK in Q1 2022 and held it in 5 quarters. The position peaked at $245K in Q1 2022. 895 funds tracked by Wall St. Rank hold GSK as of Q4 2023.

Solidarity Wealth reported no remaining GSK position as of Q4 2023 after selling out during the quarter.
Solidarity Wealth sold 5,959 GSK shares in Q4 2023, an estimated $218K.
Solidarity Wealth first reported a position in GSK in Q1 2022 and held it in 5 quarters.
Solidarity Wealth's GSK position peaked at $245K in Q1 2022.
895 funds tracked by Wall St. Rank held GSK as of Q4 2023.

Based on Solidarity Wealth's 13F filing for Q4 2023, filed 12 Feb 2024.